Results 281 to 290 of about 3,614,630 (391)
Understanding patient perspectives on the quality of family planning care: a qualitative study. [PDF]
VandeVusse A +4 more
europepmc +1 more source
A soft, stretchable, anti‐biofouling encapsulant is developed by integrating organosilicon nanowire networks with microstructured biodegradable elastomers. The hierarchical surface exhibits superhydrophobicity and enhances water barrier properties by 420% over pristine polymers, while preserving mechanical integrity.
Won Bae Han +7 more
wiley +1 more source
Availability of Eye Care Services and Management Strategies for Ocular Conditions in the uMgungundlovu District, KwaZulu-Natal. [PDF]
Mosololi R, Sukati V, Nkoana P.
europepmc +1 more source
Plug‐and‐Play Centrifuge‐Only Device for Rapid Sepsis Diagnosis
A fully automated, centrifuge‐only device can isolate and concentrate bacteria from blood for rapid sepsis diagnosis. The device enables >3×$>3\times$ bacterial enrichment and removes >$>$99.9% of blood cells. The device supports direct downstream analysis via subculturing, MALDI‐TOF, and microfluidic detection of bacteria.
Mohammad Osaid +5 more
wiley +1 more source
Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study. [PDF]
Anderson TS +6 more
europepmc +1 more source
Community Planning for Patient Care Services
openaire +3 more sources
Skin‐Interfaced Therapeutic Patches for Wound Fluid Management and Transdermal Drug Delivery
This study presents an integrated skin‐interfaced device combining microfluidics, hydrogel film technology, flexible electronics, and iontophoresis‐based transdermal delivery of PDRN to enhance wound healing. The device effectively manages wound fluid, maintains optimal moisture, and non‐invasively delivers therapeutic drugs.
Dongjun Han +5 more
wiley +1 more source
Pediatric Palliative Care Patient Transfers of Location at End-of-Life: A 7-Year Retrospective Study. [PDF]
Sun V +4 more
europepmc +1 more source
A Janus‐engineered nanoplatform (J‐pHLIP‐PD1), featuring separate tumor‐ and immune‐targeting faces, bridges melanoma cells and cytotoxic T lymphocytes using toposelective pHLIP and anti‐PD‐1 presentation. This strategy elicits robust antitumor responses, promotes immunogenic tumor cell death, suppresses lung metastasis in vivo, and provides a modular,
Alba Ortuño‐Bernal +9 more
wiley +1 more source

